Navrogen

Philadelphia, United States

Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.

Sep 2025

Grant

Top Investors

Ben Franklin Technology Partners of Southeastern PennsylvaniaNational Cancer InstituteTellus BioVentures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Navrogen's investors?

Navrogen's investors include Ben Franklin Technology Partners of Southeastern Pennsylvania, National Cancer Institute, Tellus BioVentures.

Where is Navrogen headquartered?

Navrogen is headquartered in Philadelphia, United States.

What does Navrogen do?

Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.

What stage is Navrogen at?

Navrogen is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 8, 2025.

MLA

"Navrogen — Funding & Investors." VCBacked, September 8, 2025, https://www.vcbacked.co/company/navrogen. Accessed July 1, 2026.

APA

VCBacked. (2025). Navrogen — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/navrogen

Wikipedia (cite web)

{{cite web |title=Navrogen — Funding & Investors |url=https://www.vcbacked.co/company/navrogen |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 8, 2025.